GLP-1 S
$65.99
Out of stock
Email when stock available
Description
Semaglutide is a GLP-1 receptor agonist studied for its engagement of the GLP-1 receptor. It is researched for the signaling pathways it activates and for the prolonged receptor occupancy associated with its structure.
Research context
- Studied for GLP-1-driven metabolic regulation1
- Researched for appetite and body-weight biology2
- Investigated for oral peptide delivery in metabolic research3
CAS number 910463-68-2
- Kommu S, et al. StatPearls. 2024.
- Salvador R, et al. Cureus. 2025. PMID:40143174
- Yang F, et al. Diabetes Res Clin Pract. 2021. DOI:10.1016/j.diabres.2021.108656
Intended use
Supplied strictly for laboratory research. Not for use in humans or animals, and not for use in foods, drugs, supplements, or diagnostics.
These statements have not been evaluated by the Food and Drug Administration. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. Use is restricted to qualified research professionals.
